Share on StockTwits

Questcor Pharmaceuticals (NASDAQ:QCOR) Insider Michael H. Mulroy sold 10,000 shares of the stock on the open market in a transaction dated Thursday, April 10th. The stock was sold at an average price of $85.04, for a total transaction of $850,400.00. Following the transaction, the insider now directly owns 77,063 shares in the company, valued at approximately $6,553,438. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Mizuho cut their price target on shares of Questcor Pharmaceuticals from $93.00 to $92.00 in a research note on Tuesday, April 8th. Separately, analysts at Jefferies Group downgraded shares of Questcor Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, April 8th. They now have a $86.00 price target on the stock, down previously from $89.00. Finally, analysts at Zacks upgraded shares of Questcor Pharmaceuticals from a “neutral” rating to an “outperform” rating in a research note on Thursday, March 13th. They now have a $77.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Questcor Pharmaceuticals has an average rating of “Buy” and an average price target of $85.50.

Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) traded down 2.17% on Monday, hitting $78.38. 2,610,831 shares of the company’s stock traded hands. Questcor Pharmaceuticals has a 52 week low of $27.27 and a 52 week high of $85.69. The stock’s 50-day moving average is $68.33 and its 200-day moving average is $62.46. The company has a market cap of $4.607 billion and a P/E ratio of 16.83.

Questcor Pharmaceuticals (NASDAQ:QCOR) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $243.00 million for the quarter, compared to the consensus estimate of $244.15 million. On average, analysts predict that Questcor Pharmaceuticals will post $7.05 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, July 8th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.53%.

Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.